• Chemotherapy-Free Triplet 'Sets a New Benchmark' in Follicular Lymphoma
• 'This Would Be a Hugely Important Finding': What We Heard This Week
• Alzheimer's Benefits May Continue After Donanemab Treatment Ends, Data Suggest
• Potential Game-Changing Impact on Mismatched Unrelated Blood Cell Transplantation
• TBI-Free Conditioning Before Transplant Effective in MRD-Negative B-ALL